NCT05889520

Brief Summary

In last decades, a change in dietary habits has been observed in industrialized countries characterized by a drastic increase in the consumption of ultra-processed foods (UPF, Ultra-Processed Foods). As defined by the NOVA classification, UPFs are industrial formulations of food substances added with colourings, flavourings, emulsifiers, thickeners and other additives. Among the main compounds of UPFs are the advanced glycation end-products (AGEs). Increasing evidence suggests an association between dietary exposure to AGEs and the development of chronic non-communicable diseases, such as obesity and allergies, in the general population, through increased oxidative stress and inflammation. Preliminary evidence suggests that a maternal diet rich in AGEs during pregnancy and lactation could negatively influence the composition of breast milk and have a negative impact on the infants health. However, data regarding the presence of derivatives of UPFs in breast milk are not available. The UFIM (Ultraprocessed Foods In Breast Milk) study aims at evaluate the presence of UPFs-derivatives compounds in breast milk.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
May 2023May 2026

Study Start

First participant enrolled

May 23, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 26, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 5, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2026

Last Updated

June 4, 2025

Status Verified

June 1, 2025

Enrollment Period

3 years

First QC Date

May 26, 2023

Last Update Submit

June 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To evaluate the presence of the major UPFs-derived compounds AGEs in breast milk

    Through the liquid chromatography with triple quadrupole mass spectrometric detection techniques (LC-MS/MS) will be assessed the quantity of AGEs in breast milk.

    36 months

Secondary Outcomes (3)

  • Dietary intake of UPF in lactating women

    36 months

  • Dietary intake of AGEs in lactating women

    36 months

  • Skin AGEs accumulation levels in lactating women

    36 months

Study Arms (1)

Lactacting women who are breastfeeding full-term infants

Caucasian women aged between 18 and 35 who are breastfeeding full-term infants observed at Pediatrics Section of Department of Translational Medical Sciences (University of Naples Federico II)

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Caucasian women aged between 18 and 35 who are breastfeeding full-term infants observed at Pediatrics Section of Department of Translational Medical Sciences (University of Naples Federico II)

You may qualify if:

  • Caucasian women who are breastfeeding full-term infants

You may not qualify if:

  • Non-Caucasian ethnicity;
  • Age \<18 and \>35 years;
  • Mothers of preterm children;
  • Non-exclusive breastfeeding;
  • Mothers suffering from chronic, malignancies, immunodeficiencies, chronic infections, autoimmune, inflammatory bowel disease, celiac disease, genetic-metabolic diseases, cystic fibrosis and other chronic lung diseases, cardiovascular / respiratory / intestinal malformations, neuropsychiatric disorders and pathologies neurological, vegetarian and vegan diet;
  • Mothers with tattoos, scars, moles or skin lesions on both forearms.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Traslational Medical Science - University of Naples Federico II

Naples, 80131, Italy

RECRUITING

MeSH Terms

Conditions

Child Nutrition Disorders

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Doctor of Philosophy, Full Professor

Study Record Dates

First Submitted

May 26, 2023

First Posted

June 5, 2023

Study Start

May 23, 2023

Primary Completion (Estimated)

May 23, 2026

Study Completion (Estimated)

May 23, 2026

Last Updated

June 4, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations